{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:32:05Z","timestamp":1780626725107,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Uveitic glaucoma remains challenging despite medical and surgical advancements and can potentially lead to blindness if left uncontrolled. Conservative alternatives as well as microinvasive surgeries can postpone the necessity of a highly invasive intervention. However, such procedures are still necessary to treat some refractive glaucoma cases. Since previous studies have reported excellent results following the primary implantation of glaucoma drainage devices, it was our study\u2019s aim to evaluate long-term results following a Baerveldt 250 implantation in highly complex and surgically burdened uveitic glaucoma eyes (UG) and compare these to a similar population suffering from other forms of glaucoma (OFG).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material and methods<\/jats:title>\n                <jats:p>We performed a retrospective analysis of all eyes (UG vs. OFG) following a Baerveldt 250 implant between 2013 and 2019. Efficacy parameters as well as post-operative complication data were extracted from our electronic data system for statistical analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 62 eyes were included in our study (24 UG and 38 OFG). UG baseline mean IOP was 35.04\u00a0mmHg (\u00b1\u200911.85\u00a0mmHg) with 3.08 (\u00b1\u20091.13) topical agents, and OFG was 32.63\u00a0mmHg (\u00b1\u20097.74\u00a0mmHg) with 2.68 (\u00b1\u20091.28) topical agents. A majority of eyes also required systemic acetazolamide (UG: 79% OFG: 87%) and had undergone at least one glaucoma-related operation prior to the Baerveldt 250 implant ((UG: 1.21 (\u00b1\u20090.66)), OFG: 1.74 (\u00b1\u20091.33)). At the median follow-up period (UG 592, OFG 764\u00a0days), 52.5%\/32.5% of UG\/OFG cases showed qualified success (IOP below 21\u00a0mmHg with either topical or\/and systemic medication), 15%\/30% no longer required topical medication, and 47.5% \/47.5% were free of acetazolamide systemically. Moreover, 75%\/72.5% of eyes experienced no further pressure-related surgical event. Although sight-threatening complications such as corneal and macular edema were reported in both groups, most either maintained or improved their visual acuity at the last follow-up (58.33%\/57.89%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The Baerveldt 250 implant is shown to be both effective and safe for advanced glaucoma cases in uveitis and other forms. No further glaucoma-related surgery is required in the majority of eyes in either group within a follow-up period of almost 2\u00a0years. Despite sight-threatening complications such as macular and corneal edema, visual acuity can be either maintained or improved in most eyes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00417-022-05612-x","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T08:04:33Z","timestamp":1646640273000},"page":"2991-3000","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A comparison of long-term results after Baerveldt 250 implantation in advanced uveitic  vs. other forms of glaucoma"],"prefix":"10.1007","volume":"260","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9237-8868","authenticated-orcid":false,"given":"Ioana Maria","family":"Cazana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"B\u00f6hringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"L\u00fcbke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"key":"5612_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/s0021-5155(02)00549-x","volume":"46","author":"T Takahashi","year":"2002","unstructured":"Takahashi T, Ohtani S, Miyata K et al (2002) A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol 46:556\u2013562. https:\/\/doi.org\/10.1016\/s0021-5155(02)00549-x","journal-title":"Jpn J Ophthalmol"},{"key":"5612_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000027443","volume":"213","author":"J Merayo-Lloves","year":"1999","unstructured":"Merayo-Lloves J, Power WJ, Rodriguez A et al (1999) Secondary glaucoma in patients with uveitis. Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd 213:300\u2013304. https:\/\/doi.org\/10.1159\/000027443","journal-title":"Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd"},{"key":"5612_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s0039-6257(97)00006-4","volume":"41","author":"RS Moorthy","year":"1997","unstructured":"Moorthy RS, Mermoud A, Baerveldt G et al (1997) Glaucoma associated with uveitis. Surv Ophthalmol 41:361\u2013394. https:\/\/doi.org\/10.1016\/s0039-6257(97)00006-4","journal-title":"Surv Ophthalmol"},{"key":"5612_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/archopht.1961.01840020022005","volume":"65","author":"WL Peretz","year":"1961","unstructured":"Peretz WL, Tomasi TB (1961) Aqueous hum or proteins in uveitis. Immunoelectrophoretic and gel diffusion studies on normal and pathological human aqueous humor. Arch Ophthalmol Chic Ill 1960 65:20\u201323. https:\/\/doi.org\/10.1001\/archopht.1961.01840020022005","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"5612_CR5","first-page":"477","volume":"28","author":"CB Toris","year":"1987","unstructured":"Toris CB, Pederson JE (1987) Aqueous humor dynamics in experimental iridocyclitis. Invest Ophthalmol Vis Sci 28:477\u2013481","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5612_CR6","first-page":"1274","volume":"24","author":"MF Armaly","year":"1965","unstructured":"Armaly MF, Becker B (1965) Intraocular pressure response to topical corticosteroids. Fed Proc 24:1274\u20131278","journal-title":"Fed Proc"},{"key":"5612_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/09273940902913035","volume":"17","author":"C Heinz","year":"2009","unstructured":"Heinz C, Koch JM, Zurek-Imhoff B, Heiligenhaus A (2009) Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center. Ocul Immunol Inflamm 17:243\u2013248. https:\/\/doi.org\/10.1080\/09273940902913035","journal-title":"Ocul Immunol Inflamm"},{"key":"5612_CR8","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s00417-015-3102-3","volume":"253","author":"A Anton","year":"2015","unstructured":"Anton A, Heinzelmann S, Ne\u00df T et al (2015) Trabeculectomy ab interno with the Trabectome\u00ae as a therapeutic option for uveitic secondary glaucoma. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 253:1973\u20131978. https:\/\/doi.org\/10.1007\/s00417-015-3102-3","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"5612_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00417-018-4156-9","volume":"257","author":"WD Ramdas","year":"2019","unstructured":"Ramdas WD, Pals J, Rothova A, Wolfs RCW (2019) Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature. Graefes Arch Clin Exp Ophthalmol 257:143\u2013151. https:\/\/doi.org\/10.1007\/s00417-018-4156-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5612_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/s0002-9394(99)00185-3","volume":"128","author":"P Stavrou","year":"1999","unstructured":"Stavrou P, Murray PI (1999) Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis. Am J Ophthalmol 128:434\u2013439. https:\/\/doi.org\/10.1016\/s0002-9394(99)00185-3","journal-title":"Am J Ophthalmol"},{"key":"5612_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12348-010-0012-8","volume":"1","author":"E Carre\u00f1o","year":"2011","unstructured":"Carre\u00f1o E, Villar\u00f3n S, Portero A et al (2011) Surgical outcomes of uveitic glaucoma. J Ophthalmic Inflamm Infect 1:43\u201353. https:\/\/doi.org\/10.1007\/s12348-010-0012-8","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"5612_CR12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/s0161-6420(93)31556-3","volume":"100","author":"RA Hill","year":"1993","unstructured":"Hill RA, Nguyen QH, Baerveldt G et al (1993) Trabeculectomy and Molteno implantation for glaucomas associated with uveitis. Ophthalmology 100:903\u2013908. https:\/\/doi.org\/10.1016\/s0161-6420(93)31556-3","journal-title":"Ophthalmology"},{"key":"5612_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1442-9071.2006.01241.x","volume":"34","author":"SA Vernon","year":"2006","unstructured":"Vernon SA, Koppens JM, Menon GJ, Negi AK (2006) Diode laser cycloablation in adult glaucoma: long-term results of a standard protocol and review of current literature. Clin Exp Ophthalmol 34:411\u2013420. https:\/\/doi.org\/10.1111\/j.1442-9071.2006.01241.x","journal-title":"Clin Exp Ophthalmol"},{"key":"5612_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/bjo.86.1.39","volume":"86","author":"S Ataullah","year":"2002","unstructured":"Ataullah S, Biswas S, Artes PH et al (2002) Long term results of diode laser cycloablation in complex glaucoma using the Zeiss Visulas II system. Br J Ophthalmol 86:39\u201342","journal-title":"Br J Ophthalmol"},{"key":"5612_CR15","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/S0161-6420(02)01294-0","volume":"109","author":"EM Ceballos","year":"2002","unstructured":"Ceballos EM, Parrish RK, Schiffman JC (2002) Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology 109:2256\u20132260. https:\/\/doi.org\/10.1016\/S0161-6420(02)01294-0","journal-title":"Ophthalmology"},{"key":"5612_CR16","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1080\/09273948.2018.1517892","volume":"27","author":"R Chhabra","year":"2019","unstructured":"Chhabra R, Tan SZ, Au L et al (2019) Long-term outcomes and complications of Baerveldt glaucoma drainage implants in adults with glaucoma secondary to uveitis. Ocul Immunol Inflamm 27:1322\u20131329. https:\/\/doi.org\/10.1080\/09273948.2018.1517892","journal-title":"Ocul Immunol Inflamm"},{"key":"5612_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/aos.13489","volume":"96","author":"AN Tan","year":"2018","unstructured":"Tan AN, Cornelissen MF, Webers CAB et al (2018) Outcomes of severe uveitic glaucoma treated with Baerveldt implant: can blindness be prevented? Acta Ophthalmol (Copenh) 96:24\u201330. https:\/\/doi.org\/10.1111\/aos.13489","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"5612_CR18","unstructured":"R Core Team. R: a language and environment for statistical computing. 2019. https:\/\/www.R-project.org"},{"key":"5612_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10384-015-0372-6","volume":"59","author":"SM Iverson","year":"2015","unstructured":"Iverson SM, Bhardwaj N, Shi W et al (2015) Surgical outcomes of inflammatory glaucoma: a comparison of trabeculectomy and glaucoma-drainage-device implantation. Jpn J Ophthalmol 59:179\u2013186. https:\/\/doi.org\/10.1007\/s10384-015-0372-6","journal-title":"Jpn J Ophthalmol"},{"key":"5612_CR20","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/S0161-6420(99)90532-8","volume":"106","author":"MT Britt","year":"1999","unstructured":"Britt MT, LaBree LD, Lloyd MA et al (1999) Randomized clinical trial of the 350-mm2 versus the 500-mm2 Baerveldt implant: longer term results: is bigger better? Ophthalmology 106:2312\u20132318. https:\/\/doi.org\/10.1016\/S0161-6420(99)90532-8","journal-title":"Ophthalmology"},{"key":"5612_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/B978-0-7020-5193-7.00054-6","volume-title":"Glaucoma","author":"G Holl\u00f3","year":"2015","unstructured":"Holl\u00f3 G (2015) 54 - carbonic anhydrase inhibitors. In: Shaarawy TM, Sherwood MB, Hitchings RA, Crowston JG (eds) Glaucoma, 2nd edn. W.B. Saunders, pp 559\u2013565","edition":"2"},{"key":"5612_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000320077","volume":"47","author":"MD de Smet","year":"2010","unstructured":"de Smet MD, Okada AA (2010) Cystoid macular edema in uveitis. Dev Ophthalmol 47:136\u2013147. https:\/\/doi.org\/10.1159\/000320077","journal-title":"Dev Ophthalmol"},{"key":"5612_CR23","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/eye.2016.115","volume":"30","author":"C Fardeau","year":"2016","unstructured":"Fardeau C, Champion E, Massamba N, LeHoang P (2016) Uveitic macular edema. Eye 30:1277\u20131292. https:\/\/doi.org\/10.1038\/eye.2016.115","journal-title":"Eye"},{"key":"5612_CR24","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/eye.2016.133","volume":"30","author":"RS Grajewski","year":"2016","unstructured":"Grajewski RS, Boelke AC, Adler W et al (2016) Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis. Eye Lond Engl 30:1415\u20131423. https:\/\/doi.org\/10.1038\/eye.2016.133","journal-title":"Eye Lond Engl"},{"key":"5612_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ajo.2006.07.022","volume":"143","author":"SJ Gedde","year":"2007","unstructured":"Gedde SJ, Herndon LW, Brandt JD et al (2007) Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up. Am J Ophthalmol 143:23\u201331. https:\/\/doi.org\/10.1016\/j.ajo.2006.07.022","journal-title":"Am J Ophthalmol"},{"key":"5612_CR26","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3980\/j.issn.2222-3959.2015.05.11","volume":"8","author":"TR Campagnoli","year":"2015","unstructured":"Campagnoli TR, Kim SS, Smiddy WE et al (2015) Combined pars plana vitrectomy and Baerveldt glaucoma implant placement for refractory glaucoma. Int J Ophthalmol 8:916\u2013921. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2015.05.11","journal-title":"Int J Ophthalmol"},{"key":"5612_CR27","first-page":"779","volume":"38","author":"WM Bourne","year":"1997","unstructured":"Bourne WM, Nelson LR, Hodge DO (1997) Central corneal endothelial cell changes over a ten-year period. Invest Ophthalmol Vis Sci 38:779\u2013782","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5612_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/IJG.0000000000001108","volume":"28","author":"T Higashide","year":"2019","unstructured":"Higashide T, Nishino T, Sakaguchi K et al (2019) Determinants of corneal endothelial cell loss after trabeculectomy with mitomycin C. J Glaucoma 28:61\u201367. https:\/\/doi.org\/10.1097\/IJG.0000000000001108","journal-title":"J Glaucoma"},{"key":"5612_CR29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/IJG.0b013e3181659e56","volume":"17","author":"T Storr-Paulsen","year":"2008","unstructured":"Storr-Paulsen T, Norregaard JC, Ahmed S, Storr-Paulsen A (2008) Corneal endothelial cell loss after mitomycin C-augmented trabeculectomy. J Glaucoma 17:654\u2013657. https:\/\/doi.org\/10.1097\/IJG.0b013e3181659e56","journal-title":"J Glaucoma"},{"key":"5612_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/IJG.0000000000001128","volume":"28","author":"M Kasahara","year":"2019","unstructured":"Kasahara M, Shoji N, Matsumura K (2019) The influence of trabectome surgery on corneal endothelial cells. J Glaucoma 28:150\u2013153. https:\/\/doi.org\/10.1097\/IJG.0000000000001128","journal-title":"J Glaucoma"},{"key":"5612_CR31","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/00061198-200112000-00002","volume":"10","author":"T Reinhard","year":"2001","unstructured":"Reinhard T, B\u00f6hringer D, Sundmacher R (2001) Accelerated chronic endothelial cell loss after penetrating keratoplasty in glaucoma eyes. J Glaucoma 10:446\u2013451. https:\/\/doi.org\/10.1097\/00061198-200112000-00002","journal-title":"J Glaucoma"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05612-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05612-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05612-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T10:04:21Z","timestamp":1661508261000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05612-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["5612"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05612-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"assertion":[{"value":"10 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local ethics committee of the University of Freiburg approved this retrospective observational study (vote no. 619\/19). Considering the retrospective nature of the study, no written consent to storing or analyzing data was necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}